FibroBiologics Inc
FBLG
FibroBiologics Inc AI Insights
Informational only. Not investment advice.Snapshot
- Cash burn of 16.3M TTM vs 4.9M cash on hand = ~3.6 months runway without new financing[Cash Flow TTM]
- Debt/Equity of 57x with total debt 7.1M against 125K equity - balance sheet structurally impaired[Debt to Equity]
- Zero revenue pre-clinical biotech burning 8M R&D TTM - binary outcome dependent on pipeline success[Total Revenue TTM]
Watch Triggers
- Cash and Equivalents: Falls below 2M or new financing announced — Sub-2M triggers going concern; financing terms reveal dilution severity
- Research and Development TTM: Drops >30% from 8M baseline — R&D cuts signal pipeline abandonment or pivot - existential for pre-revenue biotech
- Total Revenue TTM: Any revenue recognition >0 — First revenue (licensing, partnership) validates platform and extends runway
Bull Case
Micro-cap (11.2M market cap) with 8M R&D spend suggests meaningful pipeline activity; any positive clinical data could drive outsized returns
P/B of 90x reflects option value on fibroblast cell therapy platform - success in any indication transforms valuation
Bear Case
3.6-month cash runway with 57x leverage leaves zero margin for error - equity likely diluted 50%+ in next financing
Zero revenue, -18.5M net loss TTM, negative equity trajectory - fundamentally uninvestable without catalyst
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage FBLG's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
Imminent dilution or debt raise required within 6 months to avoid operational shutdown
- Cash burn rate 16.3M/year vs 4.9M cash
- Negative working capital of -1.5M
- No revenue to offset expenses
Valuation Context
Caveats
Public Strategies Rankings
See how FibroBiologics Inc ranks across different investment strategies.
Leverage FBLG's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
FBLG Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$12.22M | — | ||
$14.47M | — | ||
0.00 | — | ||
$0 | — | ||
$-0.53 | — | ||
0% | 0.0% | — | |
0% | 0.0% | — | |
$-16.66M | — | ||
-13 | -1025.0% | — | |
Beta 5Y (Monthly) | unknown | — |
FBLG Dividend History
FBLG Stock Splits
FBLG SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
10/31/25 | 09/30/25 | 10-Q | |
07/31/25 | 06/30/25 | 10-Q | |
05/14/25 | 03/31/25 | 10-Q | |
03/31/25 | 12/31/24 | Unknown | |
11/12/24 | 09/30/24 | 10-Q | |
08/07/24 | 06/30/24 | 10-Q | |
05/14/24 | 03/31/24 | 10-Q | |
02/29/24 | 12/31/23 | 10-K | |
01/31/24 | 09/30/23 | 424B4 | |
11/07/23 | 06/30/23 | S-1 | |
05/14/24 | 03/31/23 | 10-Q | |
01/31/24 | 12/31/22 | 424B4 | |
09/30/22 | 09/30/22 | Unknown | -- |